COYA
COYA
NASDAQ · Biotechnology

Coya Therapeutics Inc

$5.85
-0.22 (-3.62%)
As of Jun 30, 10:33 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +529.9% upside
Low Target $27.29
Average Target $36.85
High Target $45.13
Current Price $5.85
Current
$5.85
Target
$36.85
$27.29 $36.85 avg $45.13
Scenario Analysis
Bear Case
$27.29
366.5%
Low target
Base Case
$36.85
+529.9%
Avg target
Bull Case
$45.13
+671.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$7.75
-24.5% from high
52-Week Low
$3.71
+57.7% from low
Target vs 52W High
$36.85
+375.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%